about
Significant receptor affinities of metabolites and a degradation product of mometasone furoateKeys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction.Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance.Chemokine-like factor 1 (CLFK1) is over-expressed in patients with atopic dermatitis.Diagnosis and management of nasal congestion: the role of intranasal corticosteroids.New aspects of the Slug Mucosal Irritation assay: predicting nasal stinging, itching and burning sensations.Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing's syndrome from chronic, intermittent use of intranasal betamethasone.Daily versus self-adjusted dosing of topical mometasone furoate nasal spray in patients with allergic rhinitis: randomised, controlled trial.Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis.Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis.Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis.Safety of intranasal corticosteroid sprays during pregnancy: an updated review.Quality by design approach for development of suspension nasal spray products: a case study on budesonide nasal suspension.Can intranasal corticosteroids cause migraine-like headache?Efficacy of Chinese herbal medicine in treatment of allergic rhinitis in children: a meta-analysis of 19 randomized controlled trials
P2860
Q24796071-12048EAE-0CE2-4A18-9551-D436911E01D1Q36826600-337B312D-995C-4D34-9569-C479912C9CBFQ36985924-C3774097-8D69-4BE7-BC38-8B4247845E6EQ37121463-3923F2FA-1858-40C5-B71F-5ABB70A71A8AQ37380516-6788197E-8BA5-43EE-A30C-730551C2A005Q38550174-DBBE3F16-0CE2-439E-88DA-CE3A315BF4DCQ41949787-8218771B-69E2-4932-A10E-63F7AF6D182BQ43237458-8AEA6FBC-73E5-4AD1-8F15-25416611CD05Q44740263-81125E86-9A10-4A03-B2B2-CC494AAAA222Q44781855-936B7943-E232-4C0C-9F45-99252EC1F147Q45057566-7E91340F-C894-4C2B-BFDE-D73953E8D6A0Q47430686-702DD6B3-D9F5-4603-9EA4-7953C7FB0E3EQ51468748-1C3659BE-28FC-4C38-B115-4D759151BF4CQ53200781-3A4B2AB6-27FD-4B50-B1F1-6058777D7621Q58796578-DB7EC20D-A58C-46CD-8A32-3E6F25B8DDF9
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Intranasal corticosteroids for allergic rhinitis.
@ast
Intranasal corticosteroids for allergic rhinitis.
@en
Intranasal corticosteroids for allergic rhinitis.
@nl
type
label
Intranasal corticosteroids for allergic rhinitis.
@ast
Intranasal corticosteroids for allergic rhinitis.
@en
Intranasal corticosteroids for allergic rhinitis.
@nl
prefLabel
Intranasal corticosteroids for allergic rhinitis.
@ast
Intranasal corticosteroids for allergic rhinitis.
@en
Intranasal corticosteroids for allergic rhinitis.
@nl
P2093
P2860
P1433
P1476
Intranasal corticosteroids for allergic rhinitis.
@en
P2093
Amanda J Trangsrud
Amy L Whitaker
Ralph E Small
P2860
P304
P356
10.1592/PHCO.22.16.1458.33692
P407
P577
2002-11-01T00:00:00Z